L’Oréal-owned SkinCeuticals, CeraVe, and La Roche-Posay & Melanoma Research Alliance Launch Three-Year Partnership in the United States

Source: Cision PR Newswire, May 2020

WASHINGTON, May 1, 2020 /PRNewswire/ — At the start of Melanoma Awareness Month, L’Oréal-owned SkinCeuticals, CeraVe, and La Roche-Posay, the world leaders in dermocosmetics, and the Melanoma Research Alliance, the largest non-profit funder of melanoma research, announced today the start of a three-year partnership to raise awareness of melanoma and improve detection and treatment.

As part of this partnership, they have issued the L’Oréal Dermatological Beauty Brands-MRA Team Science Award to researchers at Stanford University’s School of Medicine who are studying how Artificial Intelligence (AI) within dermatologic practices can be used to improve melanoma detection.

Melanoma is the fifth most common cancer in the United States and is one of the most common cancers in young adults, especially young women. While treatments for advanced melanomas have improved significantly in the last decade, melanoma is still the deadliest of all skin cancers and this year an estimated 6,800 people will succumb to the disease. However, when caught early, melanoma is highly curable, making early detection efforts critical.

READ THE ORIGINAL FULL ARTICLE